Pulmonary Nodules in Patients with Primary Malignancy: Comparison of Hybrid PET/MR and PET/CT Imaging

Published Online:https://doi.org/10.1148/radiol.13130620

Radial volumetric interpolated breath-hold examination free-breathing MR imaging with simultaneously acquired PET data has high sensitivity in the detection of fluorodeoxyglucose-avid nodules and nodules with a diameter of at least 0.5 cm.

Purpose

To assess diagnostic sensitivity of radial T1-weighted gradient-echo (radial volumetric interpolated breath-hold examination [VIBE]) magnetic resonance (MR) imaging, positron emission tomography (PET), and combined simultaneous PET and MR imaging with an integrated PET/MR system in the detection of lung nodules, with combined PET and computed tomography (CT) as a reference.

Materials and Methods

In this institutional review board–approved HIPAA-compliant prospective study, 32 patients with tumors who underwent clinically warranted fluorine 18 (18F) fluorodeoxyglucose (FDG) PET/CT followed by PET/MR imaging were included. In all patients, the thorax station was examined with free-breathing radial VIBE MR imaging and simultaneously acquired PET data. Presence and size of nodules and FDG avidity were assessed on PET/CT, radial VIBE, PET, and PET/MR images. Percentage of nodules detected on radial VIBE and PET images was compared with that on PET/MR images by using generalized estimating equations. Maximum standardized uptake value (SUVmax) in pulmonary nodules with a diameter of at least 1 cm was compared between PET/CT and PET/MR imaging with Pearson rank correlation.

Results

A total of 69 nodules, including 45 FDG-avid nodules, were detected with PET/CT. The sensitivity of PET/MR imaging was 70.3% for all nodules, 95.6% for FDG-avid nodules, and 88.6% for nodules 0.5 cm in diameter or larger. PET/MR imaging had higher sensitivity than PET for all nodules (70.3% vs 61.6%, P = .002) and higher sensitivity than MR imaging for FDG-avid nodules (95.6% vs 80.0%, P = .008). There was a significantly strong correlation between SUVmax of pulmonary nodules obtained with PET/CT and that obtained with PET/MR imaging (r = 0.96, P < .001).

Conclusion

Radial VIBE and PET data acquired simultaneously with PET/MR imaging have high sensitivity in the detection of FDG-avid nodules and nodules 0.5 cm in diameter or larger, with low sensitivity for small non–FDG-avid nodules.

© RSNA, 2013

References

  • 1 Czernin J, Allen-Auerbach M, Schelbert HR. Improvements in cancer staging with PET/CT: literature-based evidence as of September 2006. J Nucl Med 2007;48(Suppl 1):78S–88S.
  • 2 Facey K, Bradbury I, Laking G, Payne E. Overview of the clinical effectiveness of positron emission tomography imaging in selected cancers. Health Technol Assess 2007;11(44):iii–iv, xi–267.
  • 3 Gambhir SS, Czernin J, Schwimmer J, Silverman DH, Coleman RE, Phelps ME. A tabulated summary of the FDG PET literature. J Nucl Med 2001;42(5 Suppl):1S–93S.
  • 4 Poeppel TD, Krause BJ, Heusner TA, Boy C, Bockisch A, Antoch G. PET/CT for the staging and follow-up of patients with malignancies. Eur J Radiol 2009;70(3):382–392.
  • 5 Drzezga A, Souvatzoglou M, Eiber M, et al.. First clinical experience with integrated whole-body PET/MR: comparison to PET/CT in patients with oncologic diagnoses. J Nucl Med 2012;53(6):845–855.
  • 6 Schwenzer NF, Schraml C, Müller M, et al.. Pulmonary lesion assessment: comparison of whole-body hybrid MR/PET and PET/CT imaging—pilot study. Radiology 2012;264(2):551–558.
  • 7 Werner MK, Schmidt H, Schwenzer NF. MR/PET: a new challenge in hybrid imaging. AJR Am J Roentgenol 2012;199(2):272–277.
  • 8 Sieren JC, Ohno Y, Koyama H, Sugimura K, McLennan G. Recent technological and application developments in computed tomography and magnetic resonance imaging for improved pulmonary nodule detection and lung cancer staging. J Magn Reson Imaging 2010;32(6):1353–1369.
  • 9 Stolzmann P, Veit-Haibach P, Chuck N, et al.. Detection rate, location, and size of pulmonary nodules in trimodality PET/CT-MR: comparison of low-dose CT and Dixon-based MR imaging. Invest Radiol 2013;48(5):241–246.
  • 10 Antoch G, Vogt FM, Freudenberg LS, et al.. Whole-body dual-modality PET/CT and whole-body MRI for tumor staging in oncology. JAMA 2003;290(24):3199–3206.
  • 11 Lauenstein TC, Goehde SC, Herborn CU, et al.. Whole-body MR imaging: evaluation of patients for metastases. Radiology 2004;233(1):139–148.
  • 12 Schäfer JF, Vollmar J, Schick F, et al.. Detection of pulmonary nodules with breath-hold magnetic resonance imaging in comparison with computed tomography [in German]. Rofo 2005;177(1):41–49.
  • 13 Bruegel M, Gaa J, Woertler K, et al.. MRI of the lung: value of different turbo spin-echo, single-shot turbo spin-echo, and 3D gradient-echo pulse sequences for the detection of pulmonary metastases. J Magn Reson Imaging 2007;25(1):73–81.
  • 14 Azevedo RM, de Campos RO, Ramalho M, Herédia V, Dale BM, Semelka RC. Free-breathing 3D T1-weighted gradient-echo sequence with radial data sampling in abdominal MRI: preliminary observations. AJR Am J Roentgenol 2011;197(3):650–657.
  • 15 Chandarana H, Block TK, Rosenkrantz AB, et al.. Free-breathing radial 3D fat-suppressed T1-weighted gradient echo sequence: a viable alternative for contrast-enhanced liver imaging in patients unable to suspend respiration. Invest Radiol 2011;46(10):648–653.
  • 16 DeMello LR, Rakheja R, Gilelmi C, Geppert C, Chandarana H, Friedman KP. Comparison of the accuracy of PET/CT and PET/MR spatial registration in multiple metastatic lesions [abstr]. In: Proceedings of the Twenty-First Meeting of the International Society for Magnetic Resonance in Medicine. Berkeley, Calif: International Society for Magnetic Resonance in Medicine, 2013.
  • 17 Martinez-Möller A, Eiber M, Nekolla SG, et al.. Workflow and scan protocol considerations for integrated whole-body PET/MRI in oncology. J Nucl Med 2012;53(9):1415–1426.
  • 18 Wiesmüller M, Quick HH, Navalpakkam B, et al.. Comparison of lesion detection and quantitation of tracer uptake between PET from a simultaneously acquiring whole-body PET/MR hybrid scanner and PET from PET/CT. Eur J Nucl Med Mol Imaging 2013;40(1):12–21.
  • 19 Cheng G, Torigian DA, Zhuang H, Alavi A. When should we recommend use of dual time-point and delayed time-point imaging techniques in FDG PET? Eur J Nucl Med Mol Imaging 2013;40(5):779–787.
  • 20 Costantini DL, Vali R, Chan J, McQuattie S, Charron M. Dual-time-point FDG PET/CT for the evaluation of pediatric tumors. AJR Am J Roentgenol 2013;200(2):408–413.
  • 21 Girvin F, Ko JP. Pulmonary nodules: detection, assessment, and CAD. AJR Am J Roentgenol 2008;191(4):1057–1069.
  • 22 Benjamin MS, Drucker EA, McLoud TC, Shepard JA. Small pulmonary nodules: detection at chest CT and outcome. Radiology 2003;226(2):489–493.
  • 23 Schillaci O, Travascio L, Bolacchi F, et al.. Accuracy of early and delayed FDG PET-CT and of contrast-enhanced CT in the evaluation of lung nodules: a preliminary study on 30 patients. Radiol Med (Torino) 2009;114(6):890–906.
  • 24 Cistaro A, Lopci E, Gastaldo L, Fania P, Brach Del Prever A, Fagioli F. The role of 18F-FDG PET/CT in the metabolic characterization of lung nodules in pediatric patients with bone sarcoma. Pediatr Blood Cancer 2012;59(7):1206–1210.
  • 25 Koyama H, Ohno Y, Kono A, et al.. Quantitative and qualitative assessment of non-contrast-enhanced pulmonary MR imaging for management of pulmonary nodules in 161 subjects. Eur Radiol 2008;18(10):2120–2131.

Article History

Received March 10, 2013; revision requested March 28; revision received April 25; accepted May 2; final version accepted May 10.
Published online: Sept 2013
Published in print: Sept 2013